-
2025-521841-26-00
9
2026-02-20
HIV-1 infection
-
2025-521606-18-00
4
2026-01-29
Ovarian Cancer
-
2025-523009-14-00
4
2025-12-16
Bronchiectasis with chronic pseudomonas aeruginosa colonization
-
2024-517123-39-00
6
2025-12-15
crohns disease
-
2025-523083-21-00
5
2025-12-08
PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor
-
2025-521452-30-01
5
2025-11-18
Covert brain infarction (asymptomatic brain infarctions)
-
2024-518008-33-00
5
2025-11-12
Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia due to AD)
-
2025-521405-40-01
11
2025-11-12
Adult patients undergoing tracheal intubation using video laryngoscopy
-
2024-517131-52-00
5
2025-11-03
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lym
-
2023-508056-19-00
5
2025-10-02
HER2-Expressing (IHC 3+/IHC 2+), Mismatch Repair Proficient (pMMR), P
-
2024-514822-21-00
5
2025-10-02
Platinum-resistant Ovarian Cancer
-
2024-517671-21-00
5
2025-09-30
Coronavirus Disease 2019 (COVID-19)
-
2025-520473-40-00
4
2025-09-29
Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
-
2024-519496-26-00
10
2025-09-25
Intestinal Failure
-
2025-521289-88-02
6
2025-09-01
New-onset atrial fibrillation
-
2024-518914-18-00
4
2025-08-27
Moderate to Severely Active Ulcerative Colitis & Moderate to Severely
-
2024-519331-42-00
5
2025-08-22
pMMR endometrial carcinoma
-
2023-509630-19-00
5
2025-07-31
Esophageal Squamous Cell Carcinoma (ESCC)
-
2024-520154-38-00
5
2025-07-29
Acute Myeloid Luekemia
-
2023-503184-42-00
6
2025-07-28
Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)
-
2024-517727-39-00
5
2025-07-28
Covid-19 at high risk of progression to severe illness.
-
2024-517423-40-00
5
2025-06-23
Metastatic Castration-Resistant Prostate Cancer
-
2023-510294-34-00
5
2025-06-12
small lymphocytic lymphoma (SLL)
-
2022-502184-38-00
4
2025-06-06
Rapidly progressive glomerulonephritis